COCRYSTAL PHARMA, INC. Earnings Per Share, Basic and Diluted
COCRYSTAL PHARMA, INC. (COCP) reported Earnings Per Share, Basic and Diluted of -$0.16 per share for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-23.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2022-03-23
- COCRYSTAL PHARMA, INC. earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$0.04.
- COCRYSTAL PHARMA, INC. earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$0.04.
- COCRYSTAL PHARMA, INC. earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$0.04.
- COCRYSTAL PHARMA, INC. earnings per share, basic and diluted for the quarter ending 2020-09-30 was -$0.05.
- COCRYSTAL PHARMA, INC. earnings per share, basic and diluted for fiscal 2021 was -$0.16.
- COCRYSTAL PHARMA, INC. earnings per share, basic and diluted for fiscal 2020 was -$0.17.
- COCRYSTAL PHARMA, INC. earnings per share, basic and diluted for fiscal 2019 was -$1.51.
- COCRYSTAL PHARMA, INC. earnings per share, basic and diluted for fiscal 2018 was -$1.75.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2021-12-31 | -$0.16 10-K · filed 2022-03-23 | |||
| 2021-09-30 | -$0.04 10-Q · filed 2021-11-15 | -$0.12 10-Q · filed 2021-11-15 | ||
| 2021-06-30 | -$0.04 10-Q · filed 2021-08-16 | -$0.08 10-Q · filed 2021-08-16 | ||
| 2021-03-31 | -$0.04 10-Q · filed 2021-05-17 | |||
| 2020-12-31 | -$0.17 10-K · filed 2022-03-23 | |||
| 2020-09-30 | -$0.05 10-Q · filed 2021-11-15 | -$0.16 10-Q · filed 2021-11-15 | ||
| 2020-06-30 | -$0.07 10-Q · filed 2021-08-16 | -$0.12 10-Q · filed 2021-08-16 | ||
| 2020-03-31 | -$0.05 10-Q · filed 2021-05-17 | |||
| 2019-12-31 | -$1.51 10-K · filed 2021-03-17 | |||
| 2019-09-30 | -$0.06 10-Q · filed 2020-11-13 | -$0.01 10-Q · filed 2020-11-13 | ||
| 2019-06-30 | -$0.05 10-Q · filed 2020-08-06 | $0.05 10-Q · filed 2020-08-06 | ||
| 2019-03-31 | $0.10 10-Q · filed 2020-05-13 | |||
| 2018-12-31 | -$1.75 10-K · filed 2020-03-27 | |||
| 2018-09-30 | -$0.06 10-Q · filed 2019-11-12 | -$0.17 10-Q · filed 2019-11-12 | ||
| 2018-06-30 | -$0.05 10-Q · filed 2019-08-09 | -$0.11 10-Q · filed 2019-08-09 | ||
| 2018-03-31 | -$0.06 10-Q · filed 2019-05-10 | |||
| 2017-12-31 | -$0.03 10-K · filed 2019-04-01 | |||
| 2015-03-31 | -$0.04 10-Q · filed 2015-05-14 | |||
| 2014-09-30 | -$5.37 derived: net income ÷ weighted average shares · filed 2014-11-14 | -$15.75 derived: net income ÷ weighted average shares · filed 2014-11-14 | ||
| 2014-03-31 | $0.00 10-Q · filed 2015-05-14 | |||
| 2013-09-30 | -$17.55 derived: net income ÷ weighted average shares · filed 2014-11-14 | -$54.02 derived: net income ÷ weighted average shares · filed 2014-11-14 | ||
| 2011-12-31 | -$0.11 10-K · filed 2013-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |